News Image

Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil Cream

Provided By GlobeNewswire

Last update: Jul 29, 2025

A first-of-its-kind solution for women’s arousal in a proprietary topical formulation demonstrated to work where women need it most

Targeted to be available by prescription in the fourth quarter of 2025

Read more at globenewswire.com

DARE BIOSCIENCE INC

NASDAQ:DARE (10/3/2025, 8:00:01 PM)

After market: 2.1503 -0.03 (-1.36%)

2.18

+0.03 (+1.4%)



Find more stocks in the Stock Screener

Follow ChartMill for more